Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Latest videos from the CAR-T Meeting 2021

View all
2:05
CAR-T in DLBCL: 4-year follow-up data from ZUMA-1
Anna Sureda • 9 Feb 2021
3:11
Infection prevention in patients receiving CAR T-cells
Joshua Hill • 10 Feb 2021
6:02
CAR-T vs. BiTEs in B-cell malignancies
Marion Subklewe • 11 Feb 2021
2:02
Research projects within the EN-ACTI2NG program
Hisse M. van Santen • 8 Feb 2021

Lymphoma

View all
1:34
Keynote lectures and BiTE vs CAR-T debate
Nicolaus Kröger • 27 Jan 2021
4:26
CAR-T in myeloma: key players in the therapeutic landscape
Mohamad Mohty • 26 Jan 2021

Leukemia

View all
3:04
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado • 3 Feb 2021
4:10
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian • 4 Feb 2021

Multiple Myeloma

View all
4:26
CAR-T in myeloma: key players in the therapeutic landscape
Mohamad Mohty • 26 Jan 2021
4:07
Implementation of CAR T-cell therapy in myeloma: practical and patient-related aspects
Maria-Victoria Mateos • 3 Feb 2021

Policy

View all
2:22
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
Jürgen Kuball • 27 Jan 2021
1:43
Collaboration in the field of cellular therapies
Sofie Terwel • 28 Jan 2021

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals